ClinicalTrials.govpublic full text
Impact of Hemo-dialysis Therapy on Blood Levels of Treprostenil in End Stage Renal Disease Patients With Pulmonary Hypertension
pulmonary hypertension, end-stage renal disease, hemo-dialysis therapy, remodulin (treprostenil sodium), hemo-dialysis, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 833095
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.